Clinical Trials Logo
  1. Home
  2. Aniridia
  3. NCT04117880

A Phase 2 Open Label Extension Study in Participants With Nonsense Mutation Aniridia

Aniridia Clinical Trial

Official title:
Nonsense Mutation Aniridia: An Ataluren (PTC124) Phase 2 Extension Study

Clinical Trial Summary

This is a Phase 2, multicenter, open-label study evaluating the overall systemic and ocular safety profile of ataluren in nonsense mutation aniridia as determined by the incidences of treatment-emergent adverse events (TEAEs) as well as abnormal findings on laboratory assessments, vital signs, physical examinations, ophthalmoscopy, and slit-lamp examination.

Participants who complete PTC124-GD-028 ANI (NCT02647359) meet all inclusion and none of the exclusion criteria will be enrolled into this study.

Clinical Trial Description

This study was a planned extension study of PTC124-GD-028 ANI (NCT02647359) and was never initiated. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04117880
Study type Interventional
Source PTC Therapeutics
Contact
Status Withdrawn
Phase Phase 2
Start date December 31, 2018
Completion date January 31, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT00758108 - Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
Recruiting NCT05400590 - Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients
Recruiting NCT05044598 - RAFT - Clinical Trial of RAFT for Aniridia Related Keratopathy Phase 1/Phase 2
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed NCT00001161 - Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens N/A
Enrolling by invitation NCT03461978 - Ultrahigh-resolution Optical Coherence Tomography Imaging of the Anterior Eye Segment Structures N/A
Recruiting NCT05954403 - National Cohort on Congenital Defects of the Eye
Completed NCT02647359 - Study of Ataluren in Participants With Nonsense Mutation Aniridia Phase 2
Completed NCT03581864 - Clinical Outcomes of Implantationof Black Diaphragm Intraocular Lens in Complete Aniridia and Aphakia Due to Posttraumatic Eye Rupture
Recruiting NCT05562115 - Proteomic Study of Tears From Patients With a PAX6 Mutation N/A
Completed NCT00265590 - Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia N/A
Active, not recruiting NCT00503893 - Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies
Completed NCT01644552 - Positive Angle Kappa
Completed NCT00812708 - Clinical Evaluation of Morcher Artificial Iris Diaphragms N/A